Organization: Health Canada
Year: 2023
Month: March
Request Number: A-2022-001135
Request Summary: Adverse Drug Reaction (ADR) for DEXILANT. Report number: 001009537. ADRs for ENTYVIO. Report numbers: 001009153, 001010630, E2B_05776851, E2B_05747661, E2B_05725356, E2B_05766145. ADR for VEDOLIZUMAB. Report number: 001011002.
Disposition: Disclosed in part
Number of pages: 117